Baird Maintains Neutral on Oscar Health, Raises Price Target to $33

Benzinga Newsdesk www.benzinga.com Neutral 57.3%

Neg 0% Neu 57.3% Pos 0%

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $27 to $33.

Comments

No comments yet. Be the first!